Treatment Cases

Hemicrania Continua May Respond to Repetitive Sphenopalatine Ganglion Block: A Case Report Michelle Androulakis, MD, MSc; Kaitlin A. Krebs, BA; Avi Ashkenazi, MD Background Hemicrania continua (HC) is a chronic headache disorder characterized by a continuous, strictly unilateral head pain accompanied by cranial autonomic symptoms, which completely responds to indomethacin; however, few alternative treatment options […]

Long‐Term Efficacy of a Double‐Blind, Placebo‐Controlled, Randomized Study for Repetitive Sphenopalatine Blockade With Bupivacaine vs Saline With the Tx360EU Device for Treatment of Chronic Migraine Roger K. Cady, MD; Joel Saper, MD; Kent Dexter, MD; Ryan J. Cady, MS; Heather R. Manley, MS, LPC Background This study aims to determine if repetitive sphenopalatine ganglion (SPG)

A Double-Blind, Placebo-Controlled Study of Repetitive Transnasal Sphenopalatine Ganglion Blockade With Tx360EU as Acute Treatment for Chronic Migraine Roger Cady, MD; Joel Saper, MD; Kent Dexter, MD; Heather R. Manley, MS, LPC Objective To determine if repetitive sphenopalatine ganglion (SPG) blocks with 0.5% bupivacaine delivered through the Tx360EU are superior in reducing pain associated with

A Novel Revision to the Classical Transnasal Topical Sphenopalatine Ganglion Block for the Treatment of Headache and Facial Pain Kenneth D. Candido, MD, Scott T Massey, MD, Ruben Sauer, MD, Raheleh Rahimi Darabad, MD, and Nebojsa Nick Knezevic, MD, PhD. Background The sphenopalatine ganglion (SPG) is located with some degree of variability near the tail